# Lutein for Age-Related Macular Degeneration

> **NCT00006202** · PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 45 (—)

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** Lutein

## Key facts

- **NCT ID:** NCT00006202
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 45 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006202, "Lutein for Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00006202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*